Literature DB >> 29510094

Flow Preservation of Umbilical Vein for Autologous Shunt and Cardiovascular Reconstruction.

David M Hoganson1, Dane A Cooper2, Kimberly N Rich2, Breanna L Piekarski2, Liqiong Gui3, Joseph P Gaut4, John E Mayer2, Elena Aikawa5, Laura E Niklason3, Sitaram M Emani2.   

Abstract

BACKGROUND: Synthetic graft materials are commonly used for shunts and cardiovascular reconstruction in neonates, but are prone to thrombosis and scarring. The umbilical vein is a potential source of autologous, endothelialized tissue for neonatal shunts and tissue reconstruction, but requires preservation before implantation.
METHODS: Umbilical cords were collected in UW solution with antibiotics at 4°C until dissection. Umbilical vein segments were tested for burst pressure before and after 2 weeks of preservation. Umbilical veins segments were preserved under static or flow conditions at 4°C in UW solution with 5% human plasma lysate for 7 days. Veins were evaluated with histopathology, scanning electron microscopy, and platelet adhesion testing.
RESULTS: Umbilical veins have no difference in burst pressure at harvest (n = 16) compared with 2 weeks of preservation (n = 11; 431 ± 229 versus 438 ± 244 mm Hg). After 1 week, static and flow-preserved veins showed viability of the vessel segments with endothelium staining positive for CD31, von Willebrand factor, and endothelial nitric oxide synthase. Scanning electron microscopy demonstrated preservation of normal endothelial morphology and flow alignment in the flow-preserved samples compared with cobblestone endothelial appearance and some endothelial cell loss in the static samples. Static samples had significantly more platelet adhesion than flow-preserved samples did.
CONCLUSIONS: Umbilical veins have adequate burst strength to function at neonatal systemic pressures. Preservation under flow conditions demonstrated normal endothelial and overall vascular morphology with less platelet adhesion compared with static samples. Preserved autologous umbilical veins are potential source for endothelialized shunts or cardiovascular repair tissue for neonates.
Copyright © 2018 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29510094      PMCID: PMC6292668          DOI: 10.1016/j.athoracsur.2018.01.076

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  20 in total

1.  Obstruction in modified Blalock shunts: a quantitative analysis with clinical correlation.

Authors:  Winfield J Wells; R James Yu; Anjan S Batra; Hector Monforte; Colleen Sintek; Vaughn A Starnes
Journal:  Ann Thorac Surg       Date:  2005-06       Impact factor: 4.330

2.  Clinical-scale in vitro expansion preserves biological characteristics of cardiac atrial appendage stem cells.

Authors:  S Windmolders; L Willems; A Daniëls; L Linsen; Y Fanton; M Hendrikx; R Koninckx; J-L Rummens; K Hensen
Journal:  Cell Prolif       Date:  2015-01-29       Impact factor: 6.831

3.  The role of fibrinogen spacing and patch size on platelet adhesion under flow.

Authors:  Aurore B Van de Walle; Jeffrey Fontenot; Travis G Spain; Daniel B Brunski; Ernest S Sanchez; Joel C Keay; Mark E Curtis; Matthew B Johnson; Trevor A Snyder; David W Schmidtke
Journal:  Acta Biomater       Date:  2012-07-20       Impact factor: 8.947

4.  Risk factors for mortality and morbidity after the neonatal Blalock-Taussig shunt procedure.

Authors:  Orlando Petrucci; Sean M O'Brien; Marshall L Jacobs; Jeffrey P Jacobs; Peter B Manning; Pirooz Eghtesady
Journal:  Ann Thorac Surg       Date:  2011-05-08       Impact factor: 4.330

5.  Saphenous vein homograft: a superior conduit for the systemic arterial shunt in the Norwood operation.

Authors:  V K Tam; K Murphy; W J Parks; A A Raviele; R N Vincent; M Strieper; A R Cuadrado
Journal:  Ann Thorac Surg       Date:  2001-05       Impact factor: 4.330

6.  Use of saphenous vein allografts for aortopulmonary artery anastomoses in neonates with complex cyanotic congenital heart disease.

Authors:  D Danilowicz; R G Ishmael; E F Doyle; O W Isom; S B Colvin; M A Greco
Journal:  Pediatr Cardiol       Date:  1984 Jan-Mar       Impact factor: 1.655

7.  In-hospital shunt occlusion in infants undergoing a modified blalock-taussig shunt.

Authors:  Nina A Guzzetta; Gregory S Foster; Navyata Mruthinti; Patrick D Kilgore; Bruce E Miller; Kirk R Kanter
Journal:  Ann Thorac Surg       Date:  2013-05-11       Impact factor: 4.330

8.  Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets.

Authors:  B R Alevriadou; J L Moake; N A Turner; Z M Ruggeri; B J Folie; M D Phillips; A B Schreiber; M E Hrinda; L V McIntire
Journal:  Blood       Date:  1993-03-01       Impact factor: 22.113

9.  Long-Term Expansion in Platelet Lysate Increases Growth of Peripheral Blood-Derived Endothelial-Colony Forming Cells and Their Growth Factor-Induced Sprouting Capacity.

Authors:  Dimitar Tasev; Michiel H van Wijhe; Ester M Weijers; Victor W M van Hinsbergh; Pieter Koolwijk
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

Review 10.  Diagnostic Value of Fetal Echocardiography for Congenital Heart Disease: A Systematic Review and Meta-Analysis.

Authors:  Ya-Fei Zhang; Xian-Ling Zeng; En-Fa Zhao; Hong-Wei Lu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.